Author:
Yamamura Kazuo,Kasuya Hideki,Sahin Tevfik Tolga,Tan Gewen,Hotta Yoshihiro,Tsurumaru Naoko,Fukuda Saori,Kanda Mitsuro,Kobayashi Daisuke,Tanaka Chie,Yamada Suguru,Nakayama Goro,Fujii Tsutomu,Sugimoto Hiroyuki,Koike Masahiko,Nomoto Shuji,Fujiwara Michitaka,Tanaka Maki,Kodera Yasuhiro
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Seino T, Nakadaira H, Endoh K, et al. Changes in pancreatic cancer mortality, period patterns, and birth cohort patterns in Japan: analysis of mortality data in the period 1968–2002. Environ Health Prev Med. 2008;13:234–42.
2. Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25:1960–6.
3. Teshigahara O, Goshima F, Takao K, et al. Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10. J Surg Oncol. 2004;85:42–7.
4. Shimoyama S, Goshima F, Teshigahara O, et al. Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination models. Hepatogastroenterology. 2007;54:1038–42.
5. Watanabe D, Goshima F, Mori I, Tamada Y, Matsumoto Y, Nishiyama Y. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10. J Dermatol Sci. 2008;50:185–96.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献